Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Churchill Hospital, Headington, Oxford, OX3 7LJ
After graduating from UCL with a BSc in Zoology, I joined Professor McCarthy’s group based at the Wellcome Trust for Human Genetics to carry out a genome wide scan for Type 2 diabetes (T2D) using microsatellite markers. The study involved genotyping members from T2D families and control samples. My PhD project, supervised by Professor McCarthy and Professor Marjo-Riitta Jarvelin (Imperial College) investigated the genetic aetiology of early growth and subsequent adult metabolic disease using the Northern Finland Birth Cohort of 1966 (NFBC1966).
After completing my PhD I moved from Imperial College to the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), where I was involved in replication efforts for T2D association signals identified in the Wellcome Trust Case Control Consortium (WTCCC) GWAS. In recent years I have been involved with a variety of projects coming through the McCarthy/Gloyn laboratories. My research interests include investigating the role of genetic variants and their influence on risk of metabolic traits, as well as characterising the functional consequences.
Horikoshi M, Yaghootkar H, Mook-Kanamori DO et al. New loci associated with birth weight identify geneticlinks between intrauterine growth and adult height and metabolism. Nat Genet 2013;45:76-82.
Sovio U, Bennett AJ, Millwood IY et al. Genetic determinants of height growth assessed longitudinally from infancy to adulthood in the northern Finland birth cohort 1966. PLoS Genet 2009;5:e1000409.
Freathy RM, Bennett AJ, Ring SM et al. Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes 2009 Jun;58:1428-33.
Bennett AJ, Sovio U, Ruokonen A et al. No evidence that established type 2 diabetes susceptibility variants in the PPARG and KCNJ11 genes have pleiotropiceffects on early growth. Diabetologia 2008 Jan;51:82-5.